Weight loss drugs may rewire your taste buds, study finds

NCT ID NCT07229170

Recruiting now Knowledge-focused Sponsor: San Raffaele Telematic University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks back at medical records of 150 adults aged 18-60 who took GLP-1 drugs like semaglutide for weight loss. Researchers want to understand how these drugs change taste perception, food preferences, and eating behaviors. The goal is to learn more about why these medications help people lose weight, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EATING BEHAVIOR CHANGES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Feeding Behavior Obesity obesity disorder Overweight Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EATING BEHAVIOR CHANGES OBESITY & OVERWEIGHT TASTE ALTERATIONS WEIGHT LOSS

Contacts and locations

Locations

Department for the Promotion of Human Science and Quality of Life San Raffaele Open University
RECRUITING

Rome, 00166, Italy
San Raffaele Open University
RECRUITING

Roma, Italy, 00166, Italy
San Raffaele Open University
ACTIVE_NOT_RECRUITING

Rome, 00166, Italy
San Raffaele Open University
RECRUITING

Rome, 00166, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.